NCT00545116

Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women

Short-term Effects of Hesperidin on Bone Biomarkers in Postmenopausal Women: a Randomized Placebo-controlled Trial

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 144 (actual)
• Sponsor: Société des Produits Nestlé (SPN) · Industry
• Sex: Female
• Age: 50 Years
• Healthy volunteers: Accepted

Summary

The primary objective of this clinical trial is to determine the effects of hesperidin on biochemical markers of bone in post-menopausal women. The secondary objectives are: * To investigate changes in bone formation and bone resorption markers in response to hesperidin intake * To compare the efficacy of hesperidin in a milk versus biscuit * To collect safety information of hesperidin consumption in a human trial

Conditions

• Osteopenia
• Osteoporosis

Interventions

Type	Name	Description
OTHER	Hesperidin	250 mg of hesperidin twice a day taken oraly in a biscuit or in milk for 6 months

Timeline

• Start date: 2007-10-01
• Primary completion: 2012-01-01
• Completion: 2012-01-01
• First posted: 2007-10-17
• Last updated: 2015-10-06

Locations

1 site across 1 country: Malaysia